The Presidential Commission on Bioethical Issues met earlier this month in Washington, D.C. The meeting focused on two major topics – medical emergency research and neuroscience. The first day dealt with medical emergency research and was heavily influenced by the ongoing Ebola epidemic in west Africa. The Commission heard from researchers, public health personnel and practitioners on the epidemic in Africa, efforts intended to prevent the spread of the virus in the United States, and the ethical issues associated with research on something like Ebola during an epidemic or other medical emergency.
The Commission is conducting a review of the U.S. response to the Ebola epidemic, with a focus on three issues:
- The ethics of placebo-control trials in the context of public health emergencies;
- The ethics of U.S. public policies that restrict association or movement; and
- The ethical considerations relevant to collecting and storing biospecimens during a public health emergency and sharing them for future research.
On the second day, the meeting shifted to the Commission’s ongoing work in neuroscience. The Commission intends to release volume two of its report Gray Matters sometime in the spring. Volume 1 was released in May 2014, and focused on the integration of ethics into neuroscience education. Volume 2 will tackle neural modifications, neuroscience in the legal system, and how neural capacity can affect the ability to consent in neuroscience research.
The next meeting will take place in Philadelphia May 27 and 28.